SCHEMBL7988751

SCHEMBL7988751

Cc1cccc(Cn2cnc3[nH]c(-c4ccncc4)nc(=O)c32)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNOT7 Q9UIV1 3/20 0.43
ALDH1A1 P00352 3/20 0.42
CYP11B1 P15538 2/20 0.42
CYP11B2 P19099 2/20 0.42
HPGD P15428 5/20 0.41
TSHR P16473 4/20 0.41
LMNA P02545 2/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MAPK14 Q16539 1/20 0.40
KDM4E B2RXH2 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
PARN O95453 1/20 0.39
ROCK2 O75116 1/20 0.39
ROCK1 Q13464 1/20 0.39
MAPK1 P28482 1/20 0.39
ALOX15 P16050 1/20 0.39
MMP13 P45452 1/20 0.39
MEN1 O00255 1/20 0.39
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7974270 0.92 ALDH1A1 (0.46) CNOT7ALDH1A1CYP11B1CYP11B2HPGD
SCHEMBL7985238 0.90 LMNA (0.43) CNOT7ALDH1A1CYP11B1CYP11B2HPGD
SCHEMBL7988938 0.89 CNOT7 (0.48) CNOT7ALDH1A1CYP11B1CYP11B2HPGD
SCHEMBL7988570 0.89 HPGD (0.47) CNOT7ALDH1A1CYP11B1CYP11B2HPGD
SCHEMBL7985266 0.88 CNOT7 (0.43) CNOT7CYP11B1CYP11B2MAPK14KDM4E
SCHEMBL8056886 0.88 SMN1; SMN2 (0.46) CNOT7HPGDHTTSMN1; SMN2MAPK14
SCHEMBL7985827 0.87 CNOT7 (0.49) CNOT7ALDH1A1CYP11B1CYP11B2HPGD
SCHEMBL7989314 0.87 ROCK2 (0.55) MAPK14KDM4EROCK2ROCK1
SCHEMBL7974444 0.87 CNOT7 (0.52) CNOT7ALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL7991561 0.87 HPGD (0.43) CNOT7ALDH1A1CYP11B1CYP11B2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed